Now in its 21st year, the annual International Congress on Hematologic Malignancies®: Focus on Leukemias, Lymphomas, and Myeloma is designed to facilitate clinician application of the wealth of emerging data in treating hematologic malignancies, choosing appropriate treatment based upon patient and tumor characteristics, and applying novel management strategies to their practices to improve the care of patients.
New for this year! We have shifted the meeting day pattern for this 3-day meeting to Thursday through mid-afternoon Saturday. This year’s program will focus on key clinical applications in leukemias, lymphomas, myeloma, myelodysplastic syndromes, myeloproliferative neoplasms, benign hematologic disorders, and mitigation and management of adverse events. Patient cases will be presented and discussed with the audience in a manner designed to engage their participation and in the context of methods to practically apply pivotal trial data to everyday practice. Additionally, the well-known and highly interactive Medical Crossfire® discussion panels will allow for exploration of some of the most challenging topics for which there may be many potential approaches to care.
This highly practical and interactive forum will provide a unique opportunity for oncologists and other healthcare professionals to learn from and interact with leading expert national faculty in order to increase their clinical knowledge, apply new data to practice, and ultimately improve patient outcomes.
This educational activity is directed toward community-based hematologists and medical oncologists, as well as fellows involved in the treatment and management of patients with hematologic malignancies. Nurse practitioners (NPs), nurses, physician assistants (PAs), pharmacists, researchers, and other healthcare professionals interested in the treatment of hematologic malignancies may also participate.
At the conclusion of this symposium, you should be better prepared to:
Oncology Briefings™: Updates in Therapeutic Options and Approaches for Tenosynovial Giant Cell Tumors
Apr 28, 2018
April 28, 2018
New York, NY